A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Bengt GlimeliusA Berglund

Abstract

To compare irinotecan with the Nordic 5-fluorouracil (5-FU) and folinic acid (FA) bolus schedule [irinotecan 180 mg/m(2) on day 1, 5-FU 500 mg/m(2) and FA 60 mg/m(2) on day 1 and 2 (FLIRI)] or the Lv5FU2 schedule [irinotecan 180 mg/m(2) on day 1, FA 200 mg/m(2), 5-FU bolus 400 mg/m(2) and infused 5-FU 600 mg/m(2) on day 1 and 2 (Lv5FU2-IRI)] due to uncertainties about how to administrate 5-FU with irinotecan. Patients (n = 567) with metastatic colorectal cancer were randomly assigned to receive FLIRI or Lv5FU2-IRI. Primary end point was progression-free survival (PFS). Patient characteristics were well balanced. PFS did not differ between groups (median 9 months, P = 0.22). Overall survival (OS) was also similar (median 19 months, P = 0.9). Fewer objective responses were seen in the FLIRI group (35% versus 49%, P = 0.001) but the metastatic resection rate did not differ (4% versus 6%, P = 0.3). Grade 3/4 neutropenia (11% versus 5%, P = 0.01) and grade 2 alopecia (18% versus 9%, P = 0.002) were more common in the FLIRI group. The 60-day mortality was 2.4% versus 2.1%. Irinotecan with the bolus Nordic schedule (FLIRI) is a convenient treatment with PFS and OS comparable to irinotecan with the Lv5FU2 schedule. Neutropenia and alop...Continue Reading

Citations

Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B GlimeliusB Gustavsson
Jan 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ByströmB Glimelius
Aug 13, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C SuzukiB Glimelius
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Petrelli, S Barni
Aug 23, 2012·Pharmacogenomics·Lucía Cortejoso, Luis A López-Fernández
Mar 23, 2012·Radiology·João Paulo da Silveira Nogueira LimaLucas Vieira dos Santos
Aug 8, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Cristina GrávalosAlfredo Carrato
Sep 15, 2012·Acta Oncologica·Per ByströmBengt Glimelius
Mar 12, 2010·Cancer Science·Motohiro KojimaAtsushi Ochiai
Jun 29, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S ElorantaP W Dickman
Jan 23, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Karen-Lise Garm SpindlerNils Brünner
May 24, 2015·International Journal of Colorectal Disease·Camilla S Kronborg, Anni R Jensen
Nov 2, 2018·Expert Review of Anticancer Therapy·Per PfeifferCamilla Qvortrup
Jan 17, 2012·Scandinavian Journal of Gastroenterology·Bengt Glimelius, Nina Cavalli-Björkman
Jun 19, 2019·Transplant International : Official Journal of the European Society for Organ Transplantation·Tor Magnus SmedmanSvein Dueland
Oct 22, 2008·Acta Oncologica·Per AlbertssonKlas Norrby
Feb 26, 2019·Cancer Immunology Research·Anne Hansen ReeGunhild M Mælandsmo
Nov 15, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clemens GiessenVolker Heinemann
Jul 9, 2013·Bulletin du cancer·Jean-Baptiste BachetPhilippe Rougier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Bengt GlimeliusSeppo Pyrhonen
© 2021 Meta ULC. All rights reserved